Articles from Syncell Inc.

Syncell Inc., a leader in next-generation proteomics analysis, today announced the commercial launch of Syncell Discovery Services, a global sample-to-discovery program that provides biopharma, translational research organizations, and academic institutions with direct access to results from the company’s flagship Microscoop® Mint platform.

Syncell Inc., the nanoscopic proteomics company, today announced the launch of its Synlight-Pure™ Kit, an ultra-high-precision photolabeling reagent for the company’s Microscoop® Mint platform. The kit allows life scientists to reveal unbiased proteomes within the interaction distance of 25 nanometers at microscopy-selected regions of interest, offering unmatched high specificity for a true discovery approach in tissue or cell samples.

Syncell Inc., a life science company revolutionizing spatial biology research, will showcase its innovative spatial proteomics system, Microscoop™, at the Society for Neuroscience’s (SfN) annual meeting in San Diego on November 12-16, 2022. During the Neuroscience 2022 event, Syncell will present its poster, "Microscoop, a discovery-based image-guided proteomics technology, reveals novel factors on amyloid-beta aggregates in differentiated SH-SY5Y cells," demonstrating the use of its AI-guided microscopic platform to discover novel protein markers in an Alzheimer’s Disease (AD) cell line. This research reveals the spatial proteome from amyloid-beta aggregates in SH-SY5Y cells and can also be applied to explore other neurological disorders’ biomarkers.

Syncell Inc., a leader in next-generation unbiased subcellular proteomics analysis, today announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s foremost research institutes in proteomics and advanced technology adoption. Scientists at the Max Planck Institute of Biochemistry in Germany and VIB in Belgium have implemented this groundbreaking technology in their own laboratories to uncover novel biological mechanisms, accelerate disease research, and drive innovation in drug discovery.